Related Experiment Video
Updated: Dec 25, 2025
12:14
Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
Published on: February 12, 2016
35.9K
[Acute cerebral ischemia and inflammation]
M A Evzelman1, E V Mityaeva1, I B Lashkhiia1
1Turgenev Orel State University, Orel, Russia.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|March 25, 2020
Summary
This review explores the inflammatory response in ischemic stroke (IS), detailing its mechanisms and potential biomarkers for predicting stroke severity. Understanding neuroinflammation is key to managing IS outcomes.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Ischemic stroke (IS) is a leading cause of disability and death worldwide.
- The inflammatory response plays a critical role in the pathophysiology of IS.
- Understanding neuroinflammation is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To review recent literature on the role of inflammation in ischemic stroke.
- To present data on the mechanisms of brain inflammation following ischemia.
- To identify potential biomarkers for predicting IS severity.
Main Methods:
- Literature review of recent studies on ischemic stroke and inflammation.
- Analysis of data concerning inflammatory mechanisms in the ischemic brain.
- Compilation of information on predictive markers for IS severity.
Main Results:
- The inflammatory response significantly contributes to brain damage after ischemia.
- Specific inflammatory pathways and cellular players are involved in IS.
- Several potential biomarkers for IS severity have been identified in recent studies.
Conclusions:
- Neuroinflammation is a key target for IS treatment.
- Further research is needed to validate biomarkers for clinical application.
- Targeting inflammatory pathways holds promise for improving IS outcomes.
